Intraperitoneal CAR T-cell therapy for peritoneal carcinomatosis from gastroesophageal cancer: preclinical investigations to a phase I clinical trial (NCT06623396)
Peritoneal carcinomatosis is a frequent metastatic condition in gastroesophageal cancer and is associated with poor prognosis and limited therapeutic options. Here, we establish clinically relevant mouse models of peritoneal carcinomatosis to evaluate the efficacy of a second-generation mesothelin-t...
Збережено в:
| Автори: | , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMJ Publishing Group
2025-09-01
|
| Серія: | Journal for ImmunoTherapy of Cancer |
| Онлайн доступ: | https://jitc.bmj.com/content/13/9/e012292.full |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|